Skip to main content
Premium Trial:

Request an Annual Quote

Slight Gain for BCW Index

The BCW Index rose .6 percent for the five-day trading period ended Tuesday. Though only a slight gain, it performed better than the Dow Jones Industrial Average, Nasdaq, and Nasdaq Biotech Index which fell .1 percent, .8 percent, and 1.4 percent, respectively.
 
PerkinElmer led gainers with a 3.5 percent rise, followed by Qiagen, which climbed 3.2 percent, and Bio-Rad, which closed up 3 percent. Millipore had the sharpest drop, finishing the tracking period down 1.6 percent.
 
BioCommerce Week Index of Diversified
Molecular Biology Tool Companies
Company
Ticker
Current Price
(December 12, 2006)
Last
Price
December 5, 2006)
% change
Agilent A
33.86
33.16
2.1
Applied Biosystems ABI
37.54
37.82
-0.7
Beckman BEC
59.38
60.55
-1.9
Bio-Rad BIO
84.01
81.60
3.0
Bruker BRKR
7.98
8.00
-0.2
GE GE
35.64
35.27
1.0
Invitrogen IVGN
57.67
56.90
1.4
Millipore MIL
68.79
69.89
-1.6
Molecular Devices MDCC
22.53
22.20
1.5
PerkinElmer PKI
22.26
21.50
3.5
Qiagen QGEN
14.98
14.52
3.2
Sigma SIAL
77.83
77.01
1.1
Stratagene STGN
7.52
7.55
-0.4
Thermo TMO
44.50
44.53
-0.1
Waters WAT
49.39
49.82
-0.9
BCW Index Average  
41.59
41.35
0.6

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more